Halozyme Therapeutics, Inc. (HALO) Earnings
NASDAQ·Healthcare·Biotechnology
$83.35
+0.02%
Mkt Cap $9.66B
EPS — Estimate vs Actual
Mkt Cap
$9.66B
P/E
33.80
Fwd P/E
7.47
P/S
6.92
Rev TTM
—
EPS TTM
$2.49
NASDAQ·Healthcare·Biotechnology
$83.35
+0.02%
Mkt Cap $9.66B
Mkt Cap
$9.66B
P/E
33.80
Fwd P/E
7.47
P/S
6.92
Rev TTM
—
EPS TTM
$2.49